trehalose has been researched along with Infections, Pseudomonas in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Britton, W; Chan, HK; Chang, RY; Kutter, E; Li, J; Mathai, A; Morales, S; Wong, J | 1 |
| Domon, H; Furue, Y; Hayashi, N; Isono, T; Kai, D; Kimura, T; Kurosawa, M; Maekawa, T; Oda, M; Terao, Y; Yamada, N; Yamamoto, H | 1 |
| Britton, WJ; Carrigy, NB; Chan, HK; Finlay, WH; Gao, FG; Kutter, E; Leung, SS; Morales, S; Parumasivam, T; Vehring, R | 1 |
| Eissens, AC; Hinrichs, WL; Murugappan, S; Quax, WJ; van Merkerk, R; Visser, MR; Wahjudi, M | 1 |
4 other study(ies) available for trehalose and Infections, Pseudomonas
| Article | Year |
|---|---|
Production of highly stable spray dried phage formulations for treatment of Pseudomonas aeruginosa lung infection.
Topics: Aerosols; Bacteriophages; Chemistry, Pharmaceutical; Dry Powder Inhalers; Excipients; Humans; Lactose; Leucine; Powders; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections; Trehalose | 2017 |
Sulfated vizantin induces formation of macrophage extracellular traps.
Topics: Animals; Anti-Bacterial Agents; Benzylisoquinolines; Calcium; Dimethylformamide; Drug Resistance, Multiple, Bacterial; Edetic Acid; Extracellular Traps; Glycolipids; Macrophages; Mice; Nifedipine; Phagocytosis; Pseudomonas aeruginosa; Pseudomonas Infections; RAW 264.7 Cells; Sulfates; Trehalose | 2018 |
Production of Inhalation Phage Powders Using Spray Freeze Drying and Spray Drying Techniques for Treatment of Respiratory Infections.
Topics: Administration, Inhalation; Aerosols; Freeze Drying; Leucine; Lung; Mannitol; Microbial Viability; Nebulizers and Vaporizers; Phage Therapy; Podoviridae; Powders; Pseudomonas; Pseudomonas Infections; Respiratory Tract Infections; Trehalose; Ultrasonics | 2016 |
Development of a dry, stable and inhalable acyl-homoserine-lactone-acylase powder formulation for the treatment of pulmonary Pseudomonas aeruginosa infections.
Topics: Acyl-Butyrolactones; Administration, Inhalation; Amidohydrolases; Anti-Bacterial Agents; Bacterial Proteins; Drug Stability; Escherichia coli; Excipients; Inulin; Mannitol; Microscopy, Electron, Scanning; Powder Diffraction; Powders; Pseudomonas aeruginosa; Pseudomonas Infections; Trehalose; X-Ray Diffraction | 2013 |